Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AB BioTechnologies Appoints Two New Directors | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

AB BioTechnologies Appoints Two New Directors

The new executives will lead Quality, Validation, and IT, in addition to Operations and Facilities

By: Betsy Louda

, Contract Pharma

AB BioTechnologies, Inc., a privately-held pharmaceutical contract service provider, has appointed two new executives. Bryan Hudson and Ben Lisby have joined the company as director of Quality, Validation, and IT, and director of Operations and Facilities, respectively. 

 

Hudson brings more than 22 years of industry experience to his new responsibilities of leading quality assurance, quality control, validation, and information technology initiatives. In addition, Lisby brings over 18 years of pharmaceutical contract manufacturing experience in both the facilities and process equipment arenas. 

 

“In this time of rapid transition, AB BioTechnologies relies on dedicated team members like Bryan and Ben. They bring more than four decades of combined experience to our team. Their capable leadership will ensure our expansion is quality from the ground up,” said Dr. Jeff Schwegman, chief executive officer and founder.

 

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters